Clinical Trial Update: A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia [Phase 3]

View source ↗

Summary

This clinical trial update shows a Phase 3 study evaluating Atumelnant in adults with congenital adrenal hyperplasia, including the classic form, which is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Classic Congenital Adrenal Hyperplasia
• Congenital Adrenal Hyperplasia

Drugs mentioned

• Atumelnant

Snippet

Sponsor: Crinetics Pharmaceuticals Inc. | Conditions: Congenital Adrenal Hyperplasia, Classic Congenital Adrenal Hyperplasia | Phase 3 | Status: RECRUITING